{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T12:19:40Z","timestamp":1780316380719,"version":"3.54.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T00:00:00Z","timestamp":1662076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T00:00:00Z","timestamp":1662076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["surg case rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Fungal infection may develop because of immunosuppression after organ transplantation, in which invasive types, such as <jats:italic>Aspergillus<\/jats:italic> and <jats:italic>Mucorales<\/jats:italic>, fungi cause morbidity. We present a case of disseminated mucormycosis due to <jats:italic>Cunninghamella bertholletiae<\/jats:italic> after ABO-incompatible living donor liver transplantation (LDLT).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 47-year-old man with decompensated liver cirrhosis and hepatocellular carcinoma underwent an ABO-incompatible LDLT using a graft procured from his son, who had a different blood type. Rituximab and mycophenolate mofetil were administered 3\u00a0weeks before LDLT as immunosuppressive therapy. Although liver graft function improved, mass-like infiltrates appeared in the lungs following intubation for &gt;\u20091\u00a0week due to impaired consciousness. The brain magnetic resonance imaging findings were normal. Decreased ejection fraction and ST elevation were detected on echocardiography and electrocardiography, respectively. There was no dominant stenosis on coronary arteriography. The recipient underwent segmentectomy of the right lung 20\u00a0days after LDLT. <jats:italic>C. bertholletiae<\/jats:italic> was identified from a specimen using polymerase chain reaction, thus establishing a diagnosis of mucormycosis. Multiple infarctions in the brain, heart, and kidney developed within 2\u00a0weeks. Treatment with amphotericin B was ineffective. The patient developed circulatory collapse, and a temporary pacemaker and percutaneous coronary intervention were required for cardiac infarction. The recipient died of cardiac failure 27\u00a0days after the LDLT. Autopsy revealed disseminated mucormycosis involving the brain, thyroid, heart, lung, liver, gastrointestinal tract, and both kidneys. In addition, fungal endocarditis may have been responsible for septic emboli in multiple organs, resulting in multiple organ invasion. Hypothrombocytopenia was present since the pre-transplant period, and the recipient was diagnosed posthumously with myelodysplastic syndrome due to hereditary abnormalities. Multiple factors such as organ transplantation, bone marrow dysfunction, immunosuppression, and inadequate administration of antifungal reagents might have promoted mucormycosis development in our patient.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Mucormycosis by <jats:italic>C. bertholletiae<\/jats:italic> is a fatal complication; thus, early diagnosis and treatment are warranted before multiple organ invasion.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40792-022-01516-4","type":"journal-article","created":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T04:02:48Z","timestamp":1662091368000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Fatal disseminated mucormycosis due to Cunninghamella bertholletiae infection after ABO-incompatible living donor liver transplantation: a case report"],"prefix":"10.1186","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7078-7609","authenticated-orcid":false,"given":"Atsuyoshi","family":"Mita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shohei","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Uehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Uehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunari","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Notake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Yoshizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Soejima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,2]]},"reference":[{"key":"1516_CR1","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1111\/j.1432-2277.2002.tb00176.x","volume":"15","author":"G Biancofiore","year":"2002","unstructured":"Biancofiore G, Bindi ML, Baldassarri R, Romanelli AM, Catalano G, Filipponi F, et al. Antifungal prophylaxis in liver transplant recipients: a randomized placebo-controlled study. Transpl Int. 2002;15:341\u20137.","journal-title":"Transpl Int"},{"key":"1516_CR2","doi-asserted-by":"publisher","first-page":"E298","DOI":"10.1016\/j.ijid.2011.01.005","volume":"15","author":"X Liu","year":"2011","unstructured":"Liu X, Ling ZX, Li LJ, Ruan B. Invasive fungal infections in liver transplantation. Int J Infect Dis. 2011;15:E298\u2013304.","journal-title":"Int J Infect Dis"},{"key":"1516_CR3","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.cmi.2018.07.011","volume":"25","author":"W Jeong","year":"2019","unstructured":"Jeong W, Keighley C, Wolfe R, Lee WL, Slavin MA, Kong DCM, et al. The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports. Clin Microbiol Infect. 2019;25:26\u201334.","journal-title":"Clin Microbiol Infect"},{"key":"1516_CR4","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1086\/432579","volume":"41","author":"MM Roden","year":"2005","unstructured":"Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, et al. Epidemiology and outcome of Zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41:634\u201353.","journal-title":"Clin Infect Dis"},{"key":"1516_CR5","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.ijantimicag.2019.01.002","volume":"53","author":"W Jeong","year":"2019","unstructured":"Jeong W, Keighley C, Wolfe R, Lee WL, Slavin MA, Chen SC, et al. Contemporary management and clinical outcomes of mucormycosis: a systematic review and meta-analysis of case reports. Int J Antimicrob Agents. 2019;53:589\u201397.","journal-title":"Int J Antimicrob Agents"},{"key":"1516_CR6","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1128\/AAC.00452-07","volume":"51","author":"NG Almyroudis","year":"2007","unstructured":"Almyroudis NG, Sutton DA, Fothergill AW, Rinaldi MG, Kusne S. In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents. Antimicrob Agents Chemother. 2007;51:2587\u201390.","journal-title":"Antimicrob Agents Chemother"},{"key":"1516_CR7","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s40506-019-00205-5","volume":"11","author":"P Phoompoung","year":"2019","unstructured":"Phoompoung P, Luong M-L. Treatment of non-aspergillus mold infections: a focus on mucormycosis and fusariosis. Curr Treat Options Infect Dis. 2019;11:401\u201317.","journal-title":"Curr Treat Options Infect Dis"},{"key":"1516_CR8","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1086\/651262","volume":"50","author":"PG Pappas","year":"2010","unstructured":"Pappas PG, Alexander BD, Andes DR, Hadley S, Kauffman CA, Freifeld A, et al. Invasive fungal infections among organ transplant recipients: results of the transplant-associated infection surveillance network (TRANSNET). Clin Infect Dis. 2010;50:1101\u201311.","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"1516_CR9","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1093\/cid\/cir866","volume":"54","author":"G Petrikkos","year":"2012","unstructured":"Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP. Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis. 2012;54(Suppl 1):S23-34.","journal-title":"Clin Infect Dis"},{"key":"1516_CR10","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1111\/j.1600-6143.2006.01496.x","volume":"6","author":"NG Almyroudis","year":"2006","unstructured":"Almyroudis NG, Sutton DA, Linden P, Rinaldi MG, Fung J, Kusne S. Zygomycosis in solid organ transplant recipients in a tertiary transplant center and review of the literature. Am J Transplant. 2006;6:2365\u201374.","journal-title":"Am J Transplant"},{"key":"1516_CR11","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1136\/pgmj.64.747.82","volume":"64","author":"GR Nimmo","year":"1988","unstructured":"Nimmo GR, Whiting RF, Strong RW. Disseminated mucormycosis due to Cunninghamella bertholletiae in a liver transplant recipient. Postgrad Med J. 1988;64:82\u20134.","journal-title":"Postgrad Med J"},{"key":"1516_CR12","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1111\/j.1600-6143.2009.02754.x","volume":"9","author":"HY Sun","year":"2009","unstructured":"Sun HY, Aguado JM, Bonatti H, Forrest G, Gupta KL, Safdar N, et al. Pulmonary Zygomycosis in solid organ transplant recipients in the current era. Am J Transplant. 2009;9:2166\u201371.","journal-title":"Am J Transplant"},{"key":"1516_CR13","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1086\/605445","volume":"200","author":"N Singh","year":"2009","unstructured":"Singh N, Aguado JM, Bonatti H, Forrest G, Gupta KL, Safdar N, et al. Zygomycosis in solid organ transplant recipients: a prospective, matched case-control study to assess risks for disease and outcome. J Infect Dis. 2009;200:1002\u201311.","journal-title":"J Infect Dis"},{"key":"1516_CR14","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1053\/ajkd.2002.35698","volume":"40","author":"RB Zhang","year":"2002","unstructured":"Zhang RB, Zhang JW, Szerlip HM. Endocarditis and hemorrhagic stroke caused by Cunninghamella bertholletiae infection after kidney transplantation. Am J Kidney Dis. 2002;40:842\u20136.","journal-title":"Am J Kidney Dis"},{"key":"1516_CR15","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1097\/00007890-200202150-00026","volume":"73","author":"C Jim\u00e9nez","year":"2002","unstructured":"Jim\u00e9nez C, Lumbreras C, Aguado JM, Loinaz C, Paseiro G, Andr\u00e9s A, et al. Successful treatment of mucor infection after liver or pancreas-kidney transplantation. Transplantation. 2002;73:476\u201380.","journal-title":"Transplantation"},{"key":"1516_CR16","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/sj.bmt.1705614","volume":"39","author":"SM Trifilio","year":"2007","unstructured":"Trifilio SM, Bennett CL, Yarnold PR, McKoy JM, Parada J, Mehta J, et al. Breakthrough Zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy. Bone Marrow Transplant. 2007;39:425\u20139.","journal-title":"Bone Marrow Transplant"},{"key":"1516_CR17","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1056\/NEJM200402263500923","volume":"350","author":"FM Marty","year":"2004","unstructured":"Marty FM, Cosimi LA, Baden LR. Breakthrough Zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants. N Engl J Med. 2004;350:950\u20132.","journal-title":"N Engl J Med"},{"key":"1516_CR18","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"B De Pauw","year":"2008","unstructured":"De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group. Clin Infect Dis. 2008;46:1813\u201321.","journal-title":"Clin Infect Dis"},{"issue":"810","key":"1516_CR19","first-page":"e1","volume":"22","author":"L Millon","year":"2016","unstructured":"Millon L, Herbrecht R, Grenouillet F, Morio F, Alanio A, Letscher-Bru V, et al. Early diagnosis and monitoring of mucormycosis by detection of circulating DNA in serum: retrospective analysis of 44 cases collected through the French Surveillance Network of Invasive Fungal Infections (RESSIF). Clin Microbiol Infect. 2016;22(810):e1-8.","journal-title":"Clin Microbiol Infect"},{"key":"1516_CR20","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1086\/590004","volume":"47","author":"G Chamilos","year":"2008","unstructured":"Chamilos G, Lewis RE, Kontoyiannis DP. Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with Hematologic malignancy who have Zygomycosis. Clin Infect Dis. 2008;47:503\u20139.","journal-title":"Clin Infect Dis"},{"key":"1516_CR21","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s11046-017-0149-1","volume":"182","author":"H Ota","year":"2017","unstructured":"Ota H, Yamamoto H, Kimura M, Araoka H, Fujii T, Umeyama T, et al. Successful treatment of pulmonary mucormycosis caused by Cunninghamella bertholletiae with high-dose liposomal amphotericin B (10 mg\/kg\/day) Followed by a lobectomy in Cord Blood Transplant Recipients. Mycopathologia. 2017;182:847\u201353.","journal-title":"Mycopathologia"}],"container-title":["Surgical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40792-022-01516-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40792-022-01516-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40792-022-01516-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T04:06:08Z","timestamp":1662091568000},"score":1,"resource":{"primary":{"URL":"https:\/\/surgicalcasereports.springeropen.com\/articles\/10.1186\/s40792-022-01516-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,2]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1516"],"URL":"https:\/\/doi.org\/10.1186\/s40792-022-01516-4","relation":{},"ISSN":["2198-7793"],"issn-type":[{"value":"2198-7793","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,2]]},"assertion":[{"value":"27 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This report was approved by the Ethics Committee of Shinshu University School of Medicine, Matsumoto, Japan (No. 5190) and adhered to all applicable research standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patient and his family consented to the publication of this report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"164"}}